• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Barrier-focused intervention to increase colonoscopy attendance among nonadherent high-risk populations.以屏障为重点的干预措施可提高高危未依从人群的结肠镜检查参与率。
World J Gastroenterol. 2009 Aug 21;15(31):3920-5. doi: 10.3748/wjg.15.3920.
2
[Rates on the acceptance of colonoscopy, fecal immunochemical test and a novel risk-adapted screening approach in the screening programs of colorectal cancer as well as related associated factors].[结肠镜检查、粪便免疫化学检测及一种新型风险适应性筛查方法在结直肠癌筛查项目中的接受率以及相关影响因素]
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Oct 10;41(10):1655-1661. doi: 10.3760/cma.j.cn112338-20200227-00196.
3
[Compliance rate of screening colonoscopy and its associated factors among high-risk populations of colorectal cancer in urban China].[中国城市结直肠癌高危人群筛查结肠镜检查的依从率及其相关因素]
Zhonghua Yu Fang Yi Xue Za Zhi. 2018 Mar 6;52(3):231-237. doi: 10.3760/cma.j.issn.0253-9624.2018.03.004.
4
Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.多次粪便免疫化学检测受试者的间期结直肠癌发病率。
Gastroenterology. 2017 Aug;153(2):439-447.e2. doi: 10.1053/j.gastro.2017.05.004. Epub 2017 May 5.
5
Factors Associated With Colonoscopy Compliance Based on Health Belief Model in a Community-Based Colorectal Cancer Screening Program Shanghai, China.基于健康信念模型的社区结直肠癌筛查项目中结肠镜检查依从性的相关因素分析 中国上海
Int Q Community Health Educ. 2020 Oct;41(1):25-33. doi: 10.1177/0272684X19897356. Epub 2019 Dec 26.
6
Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.种族和社会经济地位与美国南部成年人结直肠癌筛查、结直肠癌风险和死亡率的关联。
JAMA Netw Open. 2019 Dec 2;2(12):e1917995. doi: 10.1001/jamanetworkopen.2019.17995.
7
Effectiveness of a short message service intervention to motivate people with positive results in preliminary colorectal cancer screening to undergo colonoscopy: A randomized controlled trial.短信干预措施对初步结直肠癌筛查结果阳性者进行结肠镜检查的效果:一项随机对照试验。
Cancer. 2019 Jul 1;125(13):2252-2261. doi: 10.1002/cncr.32043. Epub 2019 Mar 2.
8
Participation and yield of a population-based colorectal cancer screening programme in China.中国一项基于人群的结直肠癌筛查计划的参与率和效果。
Gut. 2019 Aug;68(8):1450-1457. doi: 10.1136/gutjnl-2018-317124. Epub 2018 Oct 30.
9
Colonoscopy screening among US adults aged 40 or older with a family history of colorectal cancer.对40岁及以上有结直肠癌家族史的美国成年人进行结肠镜检查筛查。
Prev Chronic Dis. 2015 May 21;12:E80. doi: 10.5888/pcd12.140533.
10
Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.结肠镜检查外展与粪便免疫化学检测外展对结直肠癌筛查完成率的影响:一项随机临床试验。
JAMA. 2017 Sep 5;318(9):806-815. doi: 10.1001/jama.2017.11389.

引用本文的文献

1
Novel colorectal cancer screening methods - opportunities and challenges.新型结直肠癌筛查方法——机遇与挑战
Nat Rev Clin Oncol. 2025 Jun 6. doi: 10.1038/s41571-025-01037-7.
2
Effect of Behavioral Interventions on the Uptake of Colonoscopy for Colorectal Cancer Screening: A Systematic Review and Meta-Analysis.行为干预对结直肠癌筛查结肠镜检查采用率的影响:系统评价和荟萃分析。
Am J Gastroenterol. 2023 Oct 1;118(10):1829-1840. doi: 10.14309/ajg.0000000000002478. Epub 2023 Aug 22.
3
Clinical evaluation of a multitarget fecal immunochemical test-sDNA test for colorectal cancer screening in a high-risk population: a prospective, multicenter clinical study.多靶点粪便免疫化学检测-sDNA检测用于高危人群结直肠癌筛查的临床评估:一项前瞻性、多中心临床研究
MedComm (2020). 2023 Aug 12;4(4):e345. doi: 10.1002/mco2.345. eCollection 2023 Aug.
4
Implementation research on noncommunicable disease prevention and control interventions in low- and middle-income countries: A systematic review.中低收入国家非传染性疾病防控干预措施实施研究:系统评价。
PLoS Med. 2022 Jul 25;19(7):e1004055. doi: 10.1371/journal.pmed.1004055. eCollection 2022 Jul.
5
Robust performance of a novel stool DNA test of methylated SDC2 for colorectal cancer detection: a multicenter clinical study.新型粪便 DNA 甲基化 SDC2 检测用于结直肠癌检测的稳健性能:一项多中心临床研究。
Clin Epigenetics. 2020 Oct 30;12(1):162. doi: 10.1186/s13148-020-00954-x.
6
The role of SEPT9 in screening, diagnosis, and recurrence monitoring of colorectal cancer.SEPT9 在结直肠癌的筛查、诊断和复发监测中的作用。
BMC Cancer. 2019 May 14;19(1):450. doi: 10.1186/s12885-019-5663-8.
7
Invitation to Screening Colonoscopy in the Population at Familial Risk for Colorectal Cancer.家族性结直肠癌高危人群的结肠镜筛查邀请。
Dtsch Arztebl Int. 2018 Oct 26;115(43):715-722. doi: 10.3238/arztebl.2018.0715.
8
How to improve colon cancer screening rates.如何提高结肠癌筛查率。
World J Gastrointest Oncol. 2015 Dec 15;7(12):484-91. doi: 10.4251/wjgo.v7.i12.484.
9
Impact of a Multifaceted Intervention on Promoting Adherence to Screening Colonoscopy Among Persons in HIV Primary Care: A Pilot Study.多方面干预对促进HIV初级保健人群接受结肠镜筛查依从性的影响:一项试点研究。
Clin Transl Sci. 2015 Aug;8(4):290-7. doi: 10.1111/cts.12276. Epub 2015 May 21.
10
Cost-effectiveness of colorectal cancer screening protocols in urban Chinese populations.中国城市人群结直肠癌筛查方案的成本效益
PLoS One. 2014 Oct 6;9(10):e109150. doi: 10.1371/journal.pone.0109150. eCollection 2014.

本文引用的文献

1
Barriers to colorectal cancer screening: a case-control study.结直肠癌筛查的障碍:一项病例对照研究。
World J Gastroenterol. 2009 May 28;15(20):2531-6. doi: 10.3748/wjg.15.2531.
2
Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial.促进结直肠癌筛查的患者及医生提醒:一项随机对照试验
Arch Intern Med. 2009 Feb 23;169(4):364-71. doi: 10.1001/archinternmed.2008.564.
3
Physician knowledge, perceptions of barriers, and patient colorectal cancer screening practices.医生的知识、对障碍的认知以及患者的结直肠癌筛查行为。
Am J Med Qual. 2009 Mar-Apr;24(2):116-22. doi: 10.1177/1062860608328603. Epub 2009 Feb 20.
4
Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.太白山研讨会:结直肠癌筛查的障碍——经济学、能力与依从性
J Gastroenterol Hepatol. 2008 Dec;23 Suppl 2:S198-204. doi: 10.1111/j.1440-1746.2008.05556.x.
5
A culturally tailored navigator program for colorectal cancer screening in a community health center: a randomized, controlled trial.社区卫生中心针对结直肠癌筛查的文化定制导航计划:一项随机对照试验。
J Gen Intern Med. 2009 Feb;24(2):211-7. doi: 10.1007/s11606-008-0864-x.
6
Perceptions of knowledge, beliefs, and barriers to colorectal cancer screening.对结直肠癌筛查的知识、信念及障碍的认知
J Cancer Educ. 2008;23(4):238-40. doi: 10.1080/08858190802189030.
7
Interactive, culturally sensitive education on colorectal cancer screening.关于结直肠癌筛查的互动式、具有文化敏感性的教育。
Med Care. 2008 Sep;46(9 Suppl 1):S44-50. doi: 10.1097/MLR.0b013e31818105a0.
8
Increasing patient/physician communications about colorectal cancer screening in rural primary care practices.在农村基层医疗实践中加强患者与医生关于结直肠癌筛查的沟通。
Med Care. 2008 Sep;46(9 Suppl 1):S36-43. doi: 10.1097/MLR.0b013e31817c60ea.
9
Tailored navigation in colorectal cancer screening.结直肠癌筛查中的个性化导航
Med Care. 2008 Sep;46(9 Suppl 1):S123-31. doi: 10.1097/MLR.0b013e31817fdf46.
10
Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood test.不参与粪便潜血试验结直肠癌筛查项目的低优先级主要原因。
J Public Health (Oxf). 2008 Dec;30(4):461-5. doi: 10.1093/pubmed/fdn063. Epub 2008 Aug 20.

以屏障为重点的干预措施可提高高危未依从人群的结肠镜检查参与率。

Barrier-focused intervention to increase colonoscopy attendance among nonadherent high-risk populations.

作者信息

Meng Wen, Bi Xi-Wen, Bai Xiao-Yin, Pan Hua-Feng, Cai Shan-Rong, Zhao Qi, Zhang Su-Zhan

机构信息

Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China.

出版信息

World J Gastroenterol. 2009 Aug 21;15(31):3920-5. doi: 10.3748/wjg.15.3920.

DOI:10.3748/wjg.15.3920
PMID:19701973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2731255/
Abstract

AIM

To increase attendance for colonoscopy among nonadherent high-risk individuals for colorectal cancer (CRC) screening in China.

METHODS

During the first 12 mo without intervention, only 428 of the 2398 high-risk subjects attended a scheduled colonoscopy examination. The 1970 subjects who did not attend for CRC screening were enrolled in the present study. Prior barrier investigation was performed to ascertain the reasons for nonadherence. A barrier-focused intervention program was then established and implemented among eligible nonadherent subjects by telephone interviews and on-site consultations. The completion rates of colonoscopy during the first 12 mo without intervention and the second 12 mo with intervention were compared. Variations in the effect of the intervention on some high-risk factors and barrier characteristics were analyzed using logistic regression.

RESULTS

540 subjects who were not eligible were excluded from the study. The colonoscopy attendance rate was 23.04% (428/1858) during the first 12 mo without intervention, and 37.69% (539/1430) during the second 12 mo with intervention (P < 0.001). Logistic regression analysis showed that the intervention was more effective among subjects with only objective barriers (OR: 34.590, 95% CI: 23.204-51.563) or subjects with some specific high-risk characteristics: first-degree relatives diagnosed with CRC (OR: 1.778, 95% CI: 1.010-3.131), personal history of intestinal polyps (OR: 3.815, 95% CI: 1.994-7.300) and positive result for immunochemical fecal occult blood testing (OR: 2.718, 95% CI: 1.479-4.996).

CONCLUSION

The barrier-focused telephone or on-site consultation intervention appears to be a feasible means to improve colonoscopy attendance among nonadherent high-risk subjects for CRC screening in China.

摘要

目的

提高中国非依从性结直肠癌(CRC)筛查高危个体的结肠镜检查参与率。

方法

在无干预的前12个月期间,2398名高危受试者中只有428人参加了预定的结肠镜检查。1970名未参加CRC筛查的受试者被纳入本研究。进行了前期障碍调查以确定不依从的原因。然后通过电话访谈和现场咨询,在符合条件的非依从性受试者中建立并实施了以障碍为重点的干预计划。比较了无干预的前12个月和有干预的第二个12个月期间结肠镜检查的完成率。使用逻辑回归分析了干预对一些高危因素和障碍特征的影响差异。

结果

540名不符合条件的受试者被排除在研究之外。无干预的前12个月期间结肠镜检查参与率为23.04%(428/1858),有干预的第二个12个月期间为37.69%(539/1430)(P<0.001)。逻辑回归分析表明,干预在仅存在客观障碍的受试者(OR:34.590,95%CI:23.204 - 51.563)或具有某些特定高危特征的受试者中更有效:一级亲属被诊断为CRC(OR:1.778,95%CI:1.010 - 3.131)、有肠道息肉个人史(OR:3.815,95%CI:1.994 - 7.300)以及免疫化学粪便潜血检测结果为阳性(OR:2.718,95%CI:1.479 - 4.996)。

结论

以障碍为重点的电话或现场咨询干预似乎是提高中国非依从性CRC筛查高危受试者结肠镜检查参与率的可行方法。